Effect of repaglinide versus glimepiride on daily blood glucose variability and changes in blood inflammatory and oxidative stress markers

BACKGROUND: Hemoglobin A1c is the main treatment target for patients with type 2 diabetes. It has also been shown recently that postprandial glucose and daily glucose fluctuations affect the progression of diabetic complications and atherosclerotic damages. METHODS: Continuous glucose monitoring was...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Yamazaki, Masahiro, Hasegawa, Goji, Majima, Saori, Mitsuhashi, Kazuteru, Fukuda, Takuya, Iwase, Hiroya, Kadono, Mayuko, Asano, Mai, Senmaru, Takafumi, Tanaka, Muhei, Fukui, Michiaki, Nakamura, Naoto
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2014
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4026053/
https://ncbi.nlm.nih.gov/pubmed/24843385
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1758-5996-6-54
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires